We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.6B
AUM Growth
+$129M
Cap. Flow
+$58.7M
Cap. Flow %
3.67%
Top 10 Hldgs %
25.88%
Holding
122
New
4
Increased
17
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.8M
2
GS icon
Goldman Sachs
GS
+$19.9M
3
WFC icon
Wells Fargo
WFC
+$16.5M
4
ABBV icon
AbbVie
ABBV
+$15.2M
5
TFC icon
Truist Financial
TFC
+$14.5M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$23.7M
2
QCOM icon
Qualcomm
QCOM
+$20.1M
3
CVS icon
CVS Health
CVS
+$17.6M
4
VLO icon
Valero Energy
VLO
+$17M
5
ET icon
Energy Transfer Partners
ET
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.14%
2 Financials 14.05%
3 Real Estate 11.18%
4 Energy 10.09%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$324B
$46.8M 2.93%
539,280
-2,410
-0.4% -$198K
LLY icon
2
Eli Lilly
LLY
$1.07T
$44.9M 2.81%
341,456
+66,800
+24% +$7.74M
JPM icon
3
JPMorgan Chase
JPM
$939B
$44M 2.75%
315,308
-1,000
-0.3% -$128K
LMT icon
4
Lockheed Martin
LMT
$134B
$42.8M 2.67%
109,811
-300
-0.3% -$115K
VZ icon
5
Verizon
VZ
$194B
$42.5M 2.66%
692,893
-3,200
-0.5% -$193K
MSFT icon
6
Microsoft
MSFT
$2.84T
$41.2M 2.58%
261,270
-800
-0.3% -$118K
AVB icon
7
AvalonBay Communities
AVB
$27.1B
$38.8M 2.43%
184,947
-600
-0.3% -$129K
GS icon
8
Goldman Sachs
GS
$313B
$38.1M 2.39%
165,895
+91,900
+124% +$19.9M
MDT icon
9
Medtronic
MDT
$107B
$37.9M 2.37%
334,342
+32,400
+11% +$3.56M
AEP icon
10
American Electric Power
AEP
$73.7B
$36.7M 2.3%
388,293
-2,200
-0.6% -$203K
EPD icon
11
Enterprise Products Partners
EPD
$83.8B
$36.1M 2.26%
1,280,892
-3,800
-0.3% -$103K
BAC icon
12
Bank of America
BAC
$435B
$35.2M 2.2%
999,481
+428,000
+75% +$13.8M
CAG icon
13
Conagra Brands
CAG
$7.07B
$35.2M 2.2%
+1,027,000
New +$29.8M
COST icon
14
Costco
COST
$415B
$34.7M 2.17%
117,915
-300
-0.3% -$89.2K
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$34.3M 2.14%
533,992
+217,000
+68% +$12.4M
PEP icon
16
PepsiCo
PEP
$186B
$34.1M 2.13%
249,188
-500
-0.2% -$68K
PFE icon
17
Pfizer
PFE
$140B
$33.6M 2.1%
904,617
-3,899
-0.4% -$139K
GIS icon
18
General Mills
GIS
$19.2B
$33.5M 2.09%
624,621
+137,000
+28% +$7.22M
USB icon
19
US Bancorp
USB
$99.6B
$33.1M 2.07%
558,200
+84,800
+18% +$4.9M
CSCO icon
20
Cisco
CSCO
$450B
$33M 2.07%
688,929
-2,200
-0.3% -$102K
KMI icon
21
Kinder Morgan
KMI
$73.1B
$32.2M 2.02%
1,521,951
+376,900
+33% +$7.63M
DUK icon
22
Duke Energy
DUK
$102B
$32.1M 2.01%
352,087
-1,000
-0.3% -$91.7K
PSX icon
23
Phillips 66
PSX
$82.9B
$32M 2%
287,559
-900
-0.3% -$101K
ED icon
24
Consolidated Edison
ED
$41.6B
$31.9M 1.99%
352,132
-2,100
-0.6% -$188K
MCD icon
25
McDonald's
MCD
$188B
$31.8M 1.99%
160,691
-600
-0.4% -$119K

Similar funds

Payden & Rygel's Q4 2019 Portfolio in Review

As of Q4 2019, Payden & Rygel held 122 positions worth $1.6B, up 8.8% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel deployed $58.7M of net new capital in Q4 2019, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Conagra Brands: 1,027,000 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Philip Morris, an estimated $23.7M trimmed.

  • Payden & Rygel's largest Q4 2019 buy was Conagra Brands: 1,027,000 shares worth $35.2M.
  • Payden & Rygel added most to Goldman Sachs in Q4 2019, an estimated $19.9M increase.
  • Payden & Rygel's biggest Q4 2019 reduction was Philip Morris, cutting an estimated $23.7M.
  • Payden & Rygel fully exited ExxonMobil in Q4 2019, selling an estimated $60K.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.6B portfolio in Q4 2019.
  • Payden & Rygel opened 4 new positions and closed 1 in Q4 2019.
  • Payden & Rygel's portfolio value rose 8.8% quarter-over-quarter to $1.6B.

Based on Payden & Rygel's 13F filing for Q4 2019, filed 31 Jan 2020.